期刊文献+

流行性感冒病毒裂解疫苗的研制和质量控制 被引量:1

Preparation and quality control of split influenza virus vaccine
下载PDF
导出
摘要 [目的 ] 研制新型的流行性感冒病毒裂解疫苗 ,并评价其免疫效果。  [方法 ] 利用乙醚裂解流行性感冒病毒 ,制得该疫苗。  [结果 ] 三批流行性感冒病毒裂解疫苗经中国药品生物制品检定所检定合格 ,并通过临床考核 ,取得令人满意的免疫效果。  [结论 ] 该疫苗具有良好的安全性和免疫原性。 To develop split influenza virus vaccine and evaluate its immunological effect. Using ether to spilt influenza virus to produce this vaccine. Three batches of split influenza virus vaccine had passed the tests given by the National Institute of Control of Pharmaceutical and Biological Products.Besides,these vaccine had passed clinical trial with satisfactory immunological effect. [Conclusion] The study showed that this newly prepared vaccine had a desirable safety and immunogenicity.
出处 《上海预防医学》 CAS 2002年第6期253-255,共3页 Shanghai Journal of Preventive Medicine
关键词 流行性感冒病毒裂解疫苗 安全性 免疫原性 质量控制 流行性感冒 Split Influenza virus vaccine Safety Immunogenicity
  • 相关文献

参考文献5

  • 1WHO. Influenza Vaccine. WER, 2000, 75(35) :281-288
  • 2Couch, R B. Advances in influenza virus vaccine research. Ann NY Acad Sci, 1993, 685: 803~ 814
  • 3Anonymous. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices(ACIP). J MMWR,1999, 48:1 ~ 28
  • 4WHO. Requirements for Influenza Vaccine, inactived. TRS, 1991, 814:38 ~ 52
  • 5张之伦,郭晓华,孔梅,王丽华,朱向军,舒俭德,严军.流行性感冒疫苗的安全性和免疫原性观察[J].中国计划免疫,2001,7(2):79-81. 被引量:24

二级参考文献3

共引文献23

同被引文献16

  • 1T. Menegon,V. Baldo,C. Bonello,D. Dalla Costa,A. Di Tommaso,R. Trivello.Influenza vaccines: Antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population[J]. European Journal of Epidemiology . 1999 (6)
  • 2PALESE P,EAVALA F,MUSTER T,et al.Development of novel influenza virus vaccines and vectors. The Journal of Infectious Diseases . 1997
  • 3WAREING M D,TANNOCK GA.Influenza update:vaccine development and clinical trials. Current Opinion in Pulmonary Medicine . 2002
  • 4OCHIAI H,SHIBATA M,KAMIMURA K,et al.Evaluation of the efficacy of split-product trivalent A H1N1) ,AH3N2) ,and B influenza vaccines:reactogenicity,immunogenicity and persistence of antibodies following two doses of vaccines[ J]. Microbiology and Immunology . 1986
  • 5Minimum requirements for biological products . 1986
  • 6Beare,A. S.,Bynoe,M. L.Attenuation of human influenza A viruses. British Medical Journal . 1969
  • 7PB Percheson,P Trépanier,R Dugré,T Mabrouk.A phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line. Developments in Biological Standardization . 1999
  • 8Morales A,Arias Salazar J,Salazar Y,et al.A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia. Medicina(B Aires) . 2003
  • 9Yasumasa Oh,Kazuyo Ohta,Harumi Kuno-Sakai,Ryuichi Kim and Mikio Kimura.Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine. Vaccine . 1992
  • 10Guy B,Pascal N,Francon A,et al.Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine . 2001

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部